FIH Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by Univ. of Nebraska Medical Center

This novel method to advance heart transplantation utilizing DCD has the potential to increase the distance DCD donor organs can travel, thus increasing the potential donor pool

read full release

Every Possible Advantage™

At Paragonix, our mission is to create a new standard for organ preservation and transport that improves patient outcomes worldwide. We strive to protect the ultimate donation with the dignity and safety it deserves to give patients every possible advantage to thrive.

Learn MORE NOW

Every Possible Advantage™

OFFERING EVERY POSSIBLE ADVANTAGE ON THE DONOR ORGAN TRANSPLANT JOURNEY¹

Paragonix SherpaPak® Cardiac Transport System

Our flagship product, the Paragonix SherpaPak® Cardiac Transport System is the leading FDA-cleared and CE-marked medical device for heart transportation.

In 2020, the Consensus Statement from ISHLT on Donor Heart and Lung Procurement warned against the risks of tissue damage from ice and cited the Paragonix SherpaPak CTS as a new technology to prevent freezing.

Continually Improving Patient Outcomes

> 0

Donor Organs Preserved

> 0

Transplant Centers

> 0

Clinical Studies

Paragonix Technologies Application

Follow your transplant’s journey from beginning to end.

Real-time, centralized, secure coordination for transplant teams, including pairing with Paragonix organ transport systems to share organ status with the entire team.

Advancing Lung Preservation

Delivering a New Standard in Lung Preservation. Paragonix LUNGguard™ provides a sterile and temperature controlled environment for organs traveling between operating rooms. The product is designed to be easy-to-use in stressful, clinically demanding environments where there is no room for mistakes.